P P 2 2 (Pramipexole dihydrochloride 0.25 mg)
Pill imprint P P 2 2 has been identified as Pramipexole dihydrochloride 0.25 mg.
Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- P P 2 2
- 0.25 mg
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
More about pramipexole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 130 Reviews – Add your own review/rating
- Drug class: dopaminergic antiparkinsonism agents
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.